ES2161292T3 - Composicion de higiene oral. - Google Patents

Composicion de higiene oral.

Info

Publication number
ES2161292T3
ES2161292T3 ES95918809T ES95918809T ES2161292T3 ES 2161292 T3 ES2161292 T3 ES 2161292T3 ES 95918809 T ES95918809 T ES 95918809T ES 95918809 T ES95918809 T ES 95918809T ES 2161292 T3 ES2161292 T3 ES 2161292T3
Authority
ES
Spain
Prior art keywords
oral hygiene
hygiene composition
polisacaride
quitosan
sulfated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95918809T
Other languages
English (en)
Inventor
Olle Larm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medicarb AB
Original Assignee
Medicarb AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medicarb AB filed Critical Medicarb AB
Application granted granted Critical
Publication of ES2161292T3 publication Critical patent/ES2161292T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0204Specific forms not provided for by any of groups A61K8/0208 - A61K8/14
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/736Chitin; Chitosan; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/594Mixtures of polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dental Preparations (AREA)

Abstract

COMPUESTO PARA LA HIGIENE ORAL QUE CONTIENE DE FORMA COMBINADA QUITOSAN Y UN POLISACARIDO CARGADO NEGATIVAMENTE SULFATADO EN UNA CANTIDAD ACTIVA BIOLOGICAMENTE; UN PROCESO PARA MEJORAR LA HIGIENE ORAL EN LOS MAMIFEROS INCLUIDO EL SER HUMANO; Y EL USO DE QUITOSAN EN COMBINACION CON UN POLISACARIDO CARGADO NEGATIVAMENTE SULFATADO PARA LA FABRICACION DE COMPUESTOS PARA LA HIGIENE ORAL ACTIVOS DENTALMENTE.
ES95918809T 1994-05-04 1995-04-28 Composicion de higiene oral. Expired - Lifetime ES2161292T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9401540A SE518597C2 (sv) 1994-05-04 1994-05-04 Användning av kitosan i kombination med en sulfaterad, negativt laddad polysackarid för framställning av en dentalt verksam munhygienkomposition för behandling av parodontit, plaques och/eller karies

Publications (1)

Publication Number Publication Date
ES2161292T3 true ES2161292T3 (es) 2001-12-01

Family

ID=20393891

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95918809T Expired - Lifetime ES2161292T3 (es) 1994-05-04 1995-04-28 Composicion de higiene oral.

Country Status (9)

Country Link
US (1) US5711938A (es)
EP (1) EP0758223B1 (es)
JP (1) JP3342492B2 (es)
AU (1) AU687560B2 (es)
CA (1) CA2189436C (es)
DE (1) DE69521692T2 (es)
ES (1) ES2161292T3 (es)
SE (1) SE518597C2 (es)
WO (1) WO1995030403A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4941297A (en) * 1996-11-15 1998-06-10 Dumex-Alpharma A/S A method for promoting tissue repair
SE508760C2 (sv) * 1997-04-29 1998-11-02 Medicarb Ab Användning av en komposition innefattande kitosan i kombination med en polysackarid, som aktiv komponent i ett lösningsmedel, för framställning av ett spendoppningsmedel för mjölkproducerande djur
US6514950B1 (en) 1997-12-22 2003-02-04 Ciba Specialty Chemicals Corporation Use of polyanionic and polyanionically-derivatised natural polysaccharides for inhibiting alkaline phosphatase
ZA991792B (en) * 1998-04-29 1999-09-16 Trevor Wasserman Mouthwash composition.
DE19911055A1 (de) * 1999-03-12 2000-09-21 Cognis Deutschland Gmbh Verwendung von oberflächenaktiven Gemischen
FR2791262B1 (fr) * 1999-03-22 2001-09-28 Virbac Sa Compositions a base de chondroitine et de chitosan pour la protection, le traitement ou le remplacement des tissus conjonctifs
ES2169681B1 (es) * 2000-08-10 2003-10-01 Osfarma S L Metodo de produccion de filmes de quitosan con una alta capacidad de adherencia celular, producto obrenido y aplicaciones.
ATE369184T1 (de) * 2000-09-01 2007-08-15 Cognis Ip Man Gmbh Mund- und zahnpflegemittel
US6536448B2 (en) 2000-12-29 2003-03-25 Kimberly-Clark Worldwide, Inc. Hemostat coated dental floss and hemostat coated dental tape
KR100911382B1 (ko) * 2001-02-28 2009-08-07 에자끼구리고가부시키가이샤 항-충치 기능을 지닌 조성물
US20030108846A1 (en) * 2001-12-06 2003-06-12 Kimberly-Clark Worldwide, Inc. Disposable oral hygiene device and methods of making same
US7968122B2 (en) * 2003-12-10 2011-06-28 Adventrx Pharmaceuticals, Inc. Anti-viral pharmaceutical compositions
DE102004043945A1 (de) * 2004-09-11 2006-03-30 Henkel Kgaa Mund-, Zahn- und Zahnprotesenpflegemittel enthaltend die Plaquebildung inhibierende Substanzen
US20080254078A1 (en) * 2005-09-16 2008-10-16 Peter Kauper Chitosan-Based Particles
CN1939255B (zh) * 2005-09-30 2010-04-21 姚春阳 一种甲壳素牙膏
US9248079B2 (en) * 2007-05-07 2016-02-02 Koninklijke Philips N.V. Method for cleaning dental plaque from teeth using an adherent peelable gel
WO2015023226A1 (en) * 2013-08-16 2015-02-19 Exthera Ab Use of a composition comprising chitosan and a negatively charge polysaccharide for the treament of salivary dysfuntion
JP6365235B2 (ja) 2014-10-28 2018-08-01 ライオン株式会社 液状組成物

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4512968A (en) * 1982-11-30 1985-04-23 Lion Corporation Oral compositions
SE8302789D0 (sv) * 1983-05-18 1983-05-18 Andersson A E Bror Oral tandvardskomposition
US5182103A (en) * 1985-12-09 1993-01-26 Shiseido Company, Ltd. Magnesium aluminometasilicate coated composite powder and use thereof
JPH0684309B2 (ja) * 1986-03-24 1994-10-26 ライオン株式会社 人工唾液組成物
JPS62223112A (ja) * 1986-03-25 1987-10-01 Rooto Seiyaku Kk 歯周病治療剤
US4767463A (en) * 1987-04-15 1988-08-30 Union Carbide Corporation Glycosaminoglycan and cationic polymer combinations
US5036056A (en) * 1987-07-08 1991-07-30 Martin Kludas Methods for treating damaged corneal, uterine, or cartilage tissue
US5055298A (en) * 1987-12-01 1991-10-08 Chemisches Laboratorium Dr. Kurt Richter Gmbh Cosmetic composition comprising an extracellular connective tissue matrix
US4855128A (en) * 1988-01-14 1989-08-08 Warner-Lambert Company Saccharide inhibition of dental plaque
GB8803157D0 (en) * 1988-02-11 1988-03-09 Nat Res Dev Denture protection
US5041292A (en) * 1988-08-31 1991-08-20 Theratech, Inc. Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents
US4925677A (en) * 1988-08-31 1990-05-15 Theratech, Inc. Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents
US5554388A (en) * 1989-02-25 1996-09-10 Danbiosyst Uk Limited Systemic drug delivery compositions comprising a polycationi substance
US5049403A (en) * 1989-10-12 1991-09-17 Horsk Hydro A.S. Process for the preparation of surface modified solid substrates
US5213898A (en) * 1989-10-12 1993-05-25 Norsk Hydro A.S. Process for the preparation of surface modified solid substrates
US5186936A (en) * 1990-08-06 1993-02-16 Board Of Trustees Of The University Of Illinois Packing material for treatment of infections
DE4200080A1 (de) * 1992-01-03 1993-09-30 Reinmueller Johannes Pharmazeutische Zusammensetzung zur Wund-, Narben- und Keloidbehandlung
SE9300139L (sv) * 1993-01-19 1994-07-20 Medicarb Ab Framställning av ett nytt läkemedel
US5645844A (en) * 1995-06-07 1997-07-08 Chitogenics, Inc. Negatively charged chitosan derivative semiochemical delivery system

Also Published As

Publication number Publication date
WO1995030403A1 (en) 1995-11-16
SE9401540D0 (sv) 1994-05-04
CA2189436A1 (en) 1995-11-16
CA2189436C (en) 2002-06-25
SE518597C2 (sv) 2002-10-29
AU2458595A (en) 1995-11-29
JPH09512818A (ja) 1997-12-22
EP0758223B1 (en) 2001-07-11
JP3342492B2 (ja) 2002-11-11
US5711938A (en) 1998-01-27
SE9401540L (sv) 1995-11-05
DE69521692D1 (de) 2001-08-16
EP0758223A1 (en) 1997-02-19
DE69521692T2 (de) 2001-10-31
AU687560B2 (en) 1998-02-26

Similar Documents

Publication Publication Date Title
ES2161292T3 (es) Composicion de higiene oral.
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
ES2036593T3 (es) Composiciones que utilizan medicamentos antiinflamatorios no esteroidales encapsulados en liposomas.
FI973828A (fi) Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi
ES2157958T3 (es) Uso de venlafaxina o de un compuesto de ariloxipropanamina para la preparacion de un medicamento para el tratamiento de la incontinencia urinaria.
AR004348A1 (es) Reduccion del crecimiento del cabello
FI971536A (fi) Keratinosyytti-kasvutekijän analogeja
AR004700A1 (es) 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento
ATE430557T1 (de) Liposomen
ES2052066T3 (es) Mejoras en o relacionadas con compuestos organicos.
PT777482E (pt) Composicao de combinacao para utilizacao em doencas imunologicas
ES2170259T3 (es) Empleo de lipidos como agentes auxiliares en la obtencion de formas farmaceuticas solidas segun el procedimiento de extrusion en fusion.
CO5160321A1 (es) Novedosas composiciones de tipranavir y ritonavir
TR199802769T2 (xx) Terpenoid bileşikler ile antihistaminik bileşiklerin bir kombinasyonunu ihtiva eden topikal bileşim.
AR017222A1 (es) Procedimiento de utilizacion de un agente que inhibe el desarrollo de p.ovale, en la preparacion de medicamentos
AR016683A1 (es) Composicion de suministro de droga solida, anhidra, proceso y uso de una pluralidad de particulas inorganicas porosas compuestas de hidroxipatita ceramicapara su preparacion.
ES2171743T3 (es) Derivados de amidinas e isotioureas como inhibidores de la enzima sintasa de oxido nitrico.
DK0533210T3 (da) Protein C-holdige farmaceutiske præparater som midler mod inflammation.
AR004330A1 (es) Uso de inhibidores de colinesterasa en el tratamiento de xerostomia
AR008536A1 (es) Utilizacion de la tienilciclohexilamina bajo forma racemica, de diastereoisomeros o de enantiomeros sustancialmente puros, sola o en asociacioncon otras sustancias de actividad farmaceutica para preparar un medicamento destinado a limitar o inhibir los efectos debidos a productos neurotoxicos o neur
AR007059A1 (es) Uso de interferon en la preparacion de medicamentos y composiciones via oromucosal o por contacto
PE56194A1 (es) Composicion analgesica
AR008155A1 (es) Uso de un compuesto de formula i para preparar un medicamento util para tratar y prevenir la enfermedad cardiovascular post menopausica en mujeres.
AR010344A1 (es) Uso de equilenina o una sal farmaceuticamente aceptable del ester de equilenina-3-sulfato para la manufactura de un medicamento util para inhibir otratar patologias inducidas por los radicales libres y composiciones farmaceuticas
ES2060723T3 (es) Procedimiento para la obtencion de mezcla de nitrocelulosa flematizadas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 758223

Country of ref document: ES